| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |